Document Detail

Exercise-induced asthma: critical analysis of the protective role of montelukast.
MedLine Citation:
PMID:  21437147     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Exercise-induced asthma/exercise-induced bronchospasm (EIA/EIB) is a prevalent and clinically important disease affecting young children through older adulthood. These terms are often used interchangeably and the differences are not clearly defined in the literature. The pathogenesis of EIA/EIB may be different in those with persistent asthma compared to those with exercise-induced symptoms only. The natural history of EIA is unclear and may be different for elite athletes. Leukotriene biology has helped the understanding of EIB. The type and intensity of exercise are important factors for EIB. Exercise participation is necessary for proper development and control of EIA is recommended. Symptoms of EIB should be confirmed by proper testing. Biologic markers may also be helpful in diagnosis. Not all exercise symptoms are from EIB. Many medication and nonpharmacologic treatments are available. Asthma education is an important component of managing EIA. Many medications have been tested and the comparisons are complicated. Montelukast is a US Food and Drug Administration-approved asthma and EIB controller and has a number of potential advantages to other asthma medications including short onset of action, ease of use, and lack of tolerance. Not all patients improve with montelukast and rescue medication should be available.
Terrence W Carver
Related Documents :
1259017 - Modification of in vivo lacrimal gland secretion by 2,4-dinitrophenol.
25315037 - Targeting interleukin-1 in heart failure and inflammatory heart disease.
598457 - The effect of unilateral papillectomy on the juxtaglomerular granulated cells.
23400027 - Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease...
8918967 - Tolerable exercise intensity in the early rehabilitation of paraplegic patients. a prel...
21589787 - The effect of exercise on the severity of the fatigue in colorectal cancer patients who...
Publication Detail:
Type:  Journal Article     Date:  2009-10-22
Journal Detail:
Title:  Journal of asthma and allergy     Volume:  2     ISSN:  1178-6965     ISO Abbreviation:  J Asthma Allergy     Publication Date:  2009  
Date Detail:
Created Date:  2011-03-25     Completed Date:  2011-07-14     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101543450     Medline TA:  J Asthma Allergy     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  93-103     Citation Subset:  -    
The Children's Mercy Hospital and Clinics, Kansas City, MO, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ebastine in the light of CONGA recommendations for the development of third-generation antihistamine...
Next Document:  The successful treatment of vocal cord dysfunction with low-dose amitriptyline - including literatur...